Our policy on clinical research
Contact us
Get in touch with our policy team to find out more information about our work and our policies.
Medical research is vital if the UK is going to enjoy continued improvements to health. Research allows us to understand diseases better, diagnose earlier, and deliver improved outcomes with fewer side effects from treatment.
Clinical research, including trials, plays a critical role in translating scientific discoveries into safer, kinder, and more effective cancer diagnostics and treatments. As a research funder and an advocate for cancer patients, Cancer Research UK has a strong interest in ensuring that clinical research has the conditions to thrive.
To achieve this, our policy team work closely with patients, health service staff, researchers, and other organisations to raise the profile of clinical research within Government and develop policies to help make the UK a more attractive place to conduct and take part in research.
Driven by the remarkable achievements of those delivering clinical trials during the pandemic, clinical research is currently a key priority for the Government – with strong representation in multiple Government strategies.
Related documents
2023 Survey of the UK Clinical Research Workforce - Full Report (February 2024)
Beyond recovery - The case for transforming UK clinical cancer research (February 2022)
State of the cancer research workforce survey (February 2022)
Creating Time for Research full report and the supplementary survey (February 2021)
CRUK supporting statement for RCP case for research (December 2019)
Cancer Research UK’s response to the MHRA No Deal consultation (November 2018)
Cancer Research UK’s policy statement on clinical trials as the UK exits the EU (August 2018)
The Future of Clinical Trials After Brexit report (August 2018)
The Future of Clinical Trials After Brexit slide deck (August 2018)
Response to House of Commons Health Select Committee Brexit Inquiry (October 2017)
Response to Consultation on Expansion of Undergraduate Medical Education (June 2017)
Regulation and governance of health research: five years on - full report (June 2017)
Response to EU consultation on Paediatric Medicines Regulation (February 2017)
Response to EMA consultation on Good Pharmacogenomic Practice Guidance (August 2016)
Response to EU consultation on Risk proportionate approaches in clinical trials (August 2016)
Response to EU consultation on Summary of clinical trial results for laypersons (August 2016)
Response to MHRA consultation on Guidance for companion in-vitro diagnostic tests (July 2016)
Join us on Twitter/X
Join the conversation and follow @CRUK_Policy for news, updates and opinion. |
|